Following an unprecedented explosion in popularity over the last year, the U.S. CBD craze may finally be hitting some speed bumps.  

The industry has seen several setbacks in recent weeks, from the FDA issuing a warning about CBD usage to a new report this morning showing many products do not contain the amount of CBD listed on their packaging. 

Remedy Review, a natural health product testing service, conducted tests on 15 separate CBD products including oils, gummies, and capsules. Testing took place at the Avazyme, Inc. lab in North Carolina. 

According to Remedy Review’s report, 8 out of the 15 tested products were seriously mislabeled and contained at least 20% less CBD than advertised.  

Source: https://www.remedyreview.com/industry/lab-test-results/

One of the tested products — Nature’s Tru gummies — contained zero CBD despite listing a strength of 500mg on the label.  

While none of the tested products contained the exact amounts advertised, the Purekanana Natural CBD Oil 600mg, Creating Better Days Nano-CBD Full Spectrum Oil 300mg, and Real Scientific Hemp Oil RSHO-X 5000MG all were all within 10% of their advertised doses. 

Most of the remaining products varied wildly from their packaging claims, with the Everyday Optimal CBD E-Liquid 300mg containing 76% less CBD than advertised, and the Just CBD Gummies 500mg jar showing 86% less than expected. 

Aside from mislabeling, three of the products contained a pesticide, while nine contained detectable levels of heavy metals, although those levels were not sufficient to warrant a health concern.

Remedy Review’s Executive Editor Marc Lewis commented on the results of the product testing: 

Demand for CBD has outpaced quality control standards. Brands that bring poor quality products to market put consumers at risk, waste people’s money, and erode trust in a promising new product category.

A wide range of CBD products have hit mom-and-pop stores as well as gas station convenience shops around the country since the 2018 Farm Bill legalized industrial hemp growing. 

Major licensed producers in the cannabis industry have also jumped on the CBD train in the U.S. and seen products landing in a variety of highly visible traffic sites. 

Green Growth Brands (CSE: GGB; OTCQB: GGBXF) for instance has opened more than 150 topical CBD mall kiosks under the Seventh Sense Botanicals brand name this year. 

Charlotte’s Web (CSE: CWEB; OTCQX: CWBHF) also saw products hitting hundreds of stores in 2019 between deals with The Vitamin Shoppe and the Kroger line of grocery chains.